Aclidinium Bromide is a much higher propensity to bind to muscarinic receptors than nicotinic receptors. FDA approved on July 24, 2012. Aclidinium is an anticholinergic for the long-term management of chronic obstructive pulmonary disease. Reference standards of Aclidinium Bromide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Aclidinium Bromide
Catalogue No.:PA 28 81000
CAS :
Molecular Formula : C26H30BrNO4S2
Molecular Weight : 564.5
2-(2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy)-2,2-di(thiophen-2-yl)acetic Acid
Catalogue No.:PA 28 0811002
Molecular Formula : C20H14O5S4
Molecular Weight : 462.57
(R)-1-(3-Bromopropyl)-3-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)quinuclidin-1-ium Bromide
Catalogue No.:PA 28 0811003
Molecular Formula : C20H25Br2NO3S2
Molecular Weight : 551.35
(3R,3'R)-1,1'-(propane-1,3-diyl)bis(3-(2-hydroxy-2,2-di(thiophen-2-yl)acetoxy)quinuclidin-1-ium) Bromide
Catalogue No.:PA 28 0811004
Molecular Formula : C37H44Br2N2O6S4
Molecular Weight : 900.82
(1S,3R,4S)-Quinuclidin-3-yl thiophene-2-carboxylate
Catalogue No.:PA 28 0811000
Molecular Formula : C12H15NO2S
Molecular Weight : 237.32
(3R)-4-(2-Hydroxyethyl)-1-(3-phenoxypropyl)piperidin-3-ol
Catalogue No.:PA 28 0811001
Molecular Formula : C16H25NO3
Molecular Weight : 279.38
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
